About this trial
The aim of this study is to report the proportion of patients with acute hypoxemic respiratory failyre (AHRF) undergoing mechanical ventilation who exceed 17 J/min of mechanical power (MP) and the difference in terms of proinflammatory cytokine concentration in blood samples and bronchoalveolar lavage.
The main questions it aims to answer are:
1. Which is the proportion of patients who exceed 17 J/min of mechanical power (MP) during the first 72 hours of mechanical ventilation? 2. Is there a difference in terms of cytokine concentration in patients undergoing mechanical power \>17 J/min compared to \<17 J/min?
Patients will be divided into two groups based on respiratory mechanics measurements: low MP group (average MP \<17 J/min) and high MP group (average MP ≥17 J/min). The researchers will collect blood and BAL samples and perform cytokine assays.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with AHRF (P/F <300 mmHg) undergoing invasive mechanical ventilation within 7 days from the onset of symptoms
Invasive mechanical ventilation for less than 6 hours
Evidence of newly developed lung consolidation on chest imaging (X-ray, CT)
Age ≥18 years
Disqualifiers
Prior invasive mechanical ventilation during the same hospitalization
Tracheostomy
Severe anemia (Hb<7g/dL)
Severe neutropenia
Trial population
Patients with AHRF undergoing mechanical ventilation
Trial design
Cohort
Prospective
Treatments tested in this trial
Mechanical ventilation
DeviceMechanical ventilatiom
Treatment groups
Trial outcomes
Primary outcomes
Patients who exceed 17 J/min of MP
Proportion of patients with AHRF undergoing mechanical ventilation who exceed 17 J/min of MP
Secondary outcomes
Inflammatory cytokines
Difference in terms of proinflammatory cytokine concentration in blood samples and bronchoalveolar lavage.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.